{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"7"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"120"}],"units":"Participants"}],"description":"Assessment of treatment response was determined by MRI in conjunction with neurological examination and steroid requirement assessment derived from Macdonald's criteria. Complete response was defined as complete disappearance of lesion on consecutive MRI scans with stable or improved neuro exam and steroids. Partial response was defined as a 50% reduction in lesion size or that tumor burden was \"definitely better\" than prior scan with stable or improved neuro exam and steroids.","groups":[{"description":"Temozolomide\n\ntemozolomide: Chemotherapy","id":"OG000","title":"Temozolomide"}],"paramType":"COUNT_OF_PARTICIPANTS","reportingStatus":"POSTED","timeFrame":"12 months","title":"Response Rate (Complete and Partial Response)","type":"PRIMARY","unitOfMeasure":"Participants"}